Publications by authors named "S Norley"

Claim this Profile
C
Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.
Yoshita Bhide, Wei Dong, Inta Gribonika, Daniëlle Voshart, Tjarko Meijerhof, Stephen Norley

Front Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No significant HTLV seroprevalence in German people who inject drugs.
Oliver Hohn, Stephen Norley, Claudia Kücherer, Ali Bazarbachi, Hiba El Hajj

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus.
Olaf Pinkenburg, Torben Meyer, Norbert Bannert, Steven Norley, Kathrin Bolte

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
Eva van Doorn, Olga Pleguezuelos, Heng Liu, Ana Fernandez, Robin Bannister, Stephen Norley

BMC Infect Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.
Eva van Doorn, Heng Liu, Tamar Ben-Yedidia, Shimon Hassin, Ildiko Visontai, Stephen Norley

Medicine (Baltimore)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis